Enter assignee name

EPO Patents = 3

Forward Citations = 2

Loading Chart...

10 inventors (with patents filed for the assignee):

Alexis Weston (7 out of 7 patents)

Mohan Rao Kaadige (7 out of 7 patents)

Sunil Sharma (7 out of 21 patents)

4. Trason Thode (6 out of 6 patents)

5. Srinivas Rao Kasibhatla (4 out of 26 patents)

6. Hariprasad Vankayalapati (3 out of 51 patents)

7. Raman Kumar Kalakuntla (2 out of 2 patents)

8. Xiaohui Liu (1 out of 11 patents)

9. Gurusankar Ramamoorthy (1 out of 1 patent)

10. Raman Kumar Kalakuntla (0 patent)

7 patents: Sort by Forward Citations

1. 12741963 - Imidazole compounds as inhibitors of ENPP1 (2026-09-22),

2. 12653835 - Phosphonates as inhibitors of ENPP1 and CDNP (2026-06-16),

3. 12152015 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2024-11-26),

4. 11591313 - Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) and methods of use thereof (2023-02-28),

5. 11407729 - Quinoline and quinazoline compounds and methods of use thereof (2022-08-09),

6. 11142524 - Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2021-10-12),

7. 10689376 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2020-06-23),

Stingray Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for cancer. With a team of experienced researchers and scientists, Stingray is dedicated to advancing precision oncology through innovative drug discovery and development. Their cutting-edge approach aims to address unmet medical needs and improve patient outcomes in the fight against cancer.

Profile summary based on public USPTO records.